ESR1 and breast cancer: In a study involving 535,941 breast cancer patients [15], the results indicated that a positive estrogen receptor status (RR = 0.93 and p = 0.014) and positive progesterone receptor status (RR = 0.86 and p < 0.001) were associated with a lower risk of developing BC-LuC.